Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B

被引:2
|
作者
Park, Yewan [1 ,2 ]
Kang, Danbee [3 ,4 ]
Sinn, Dong Hyun [2 ,5 ]
Kim, Hyunsoo [4 ]
Hong, Yun Soo [6 ,7 ]
Cho, Juhee [3 ,4 ,6 ,7 ]
Gwak, Geum-Youn [5 ]
机构
[1] Kyung Hee Univ Hosp, Dept Internal Med, Seoul 02447, South Korea
[2] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul 06355, South Korea
[3] Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul 06355, South Korea
[4] Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Seoul 06351, South Korea
[5] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul 06351, South Korea
[6] Johns Hopkins Med Inst, Dept Epidemiol & Med, Baltimore, MD 21287 USA
[7] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA
关键词
Lifestyle modification; Chronic hepatitis B; Hepatocellular carcinoma; Cancer; Mortality; CHRONIC VIRAL-HEPATITIS; COFFEE CONSUMPTION; CIGARETTE-SMOKING; LIVER-CANCER; ALCOHOL; RISK; INFECTION; DRINKING; TOBACCO;
D O I
10.3748/wjg.v29.i24.3843
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Research exploring the influence of healthier lifestyle modification (LSM) on the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is limited. AIM To emulate a target trial to determine the effect of LSM on HCC incidence and mortality among patients with CHB by large-scale population-based observational data. METHODS Among the patients with CHB enrolled in the Korean National Health Insurance Service between January 1, 2009, and December 31, 2017, those aged >= 20 years who drank alcohol, smoked cigarettes, and were sedentary were analyzed. Exposure included at least one LSM, including alcohol abstinence, smoking cessation, and regular exercise. The primary outcome was HCC development, and the secondary outcome was liver-related mortality. We used 2:1 propensity score matching to account for covariates. RESULTS With 48766 patients in the LSM group and 103560 in the control group, the adjusted hazard ratio (HR) for incident HCC and liver-related mortality was 0.92 [95% confidence interval (CI): 0.87-0.96] and 0.92 (95%CI: 0.86-0.99) in the LSM group, respectively, compared with the control group. Among the LSM group, the adjusted HR (95%CI) for incident HCC was 0.84 (0.76-0.94), 0.87 (0.81-0.94), and 1.08 (1.00-1.16) for alcohol abstinence, smoking cessation, and regular exercise, respectively. The adjusted HR (95%CI) for liver-related mortality was 0.92 (0.80-1.06), 0.81 (0.72-0.91), and 1.15 (1.04-1.27) for alcohol abstinence, smoking cessation, and regular exercise, respectively. CONCLUSION LSM lowered the risk of HCC and mortality in patients with CHB. Thus, active LSM, particularly alcohol abstinence and smoking cessation, should be encouraged in patients with CHB. (c) The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:3843 / 3854
页数:12
相关论文
共 50 条
  • [31] Incidence of Hepatocellular Carcinoma after HBsAg seroclearance in Chronic Hepatitis B patients: a need for Surveillance
    Kim, Gi-Ae
    Lee, Han Chu
    Ha, Yeonjung
    Park, Eui Ju
    An, Jihyun
    HEPATOLOGY, 2014, 60 : 972A - 972A
  • [32] METABOLIC SYNDROME INCREASES THE INCIDENCE OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA DEVELOPMENT IN PATIENTS WITH CHRONIC HEPATITIS B
    Li, Jie
    Chaung, Kevin T.
    Nguyen, Pauline
    Le, An K.
    Hoang, Joseph
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1072 - S1072
  • [33] Treatment and Hepatocellular Carcinoma Screening Patterns Among Black Patients With Chronic Hepatitis B
    Rao, Sanjana
    Atuluru, Pranusha
    Kleyman, Leo S.
    Sirisha, Gaddipati
    Elmengad, Malika
    Jones, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S871 - S872
  • [34] RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH ENTECAVIR
    Yamada, R.
    Hiramatsu, N.
    Morishita, N.
    Harada, N.
    Oze, T.
    Yakushijin, T.
    Miyagi, T.
    Yoshida, Y.
    Tatsumi, T.
    Ohkawa, K.
    Kasahara, A.
    Mita, E.
    Hagiwara, H.
    Oshita, M.
    Itoh, T.
    Hijioka, T.
    Yoshihara, H.
    Imai, Y.
    Hayashi, N.
    Takehara, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S425 - S425
  • [35] Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B
    Lv, Duo-Duo
    Wang, You-Juan
    Wang, Meng-Lan
    Chen, En-Qiang
    Tao, Ya-Chao
    Zhang, Dong-Mei
    Tang, Hong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] EFFECT OF INTERFERON ALFA-2B PLUS RIBAVIRIN THERAPY ON INCIDENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS
    Kurokawa, Mika
    Hiromotsu, Nooki
    Takeharo, Tetsuo
    Ozel, Tsugiko
    Yakushijin, Takayuki
    Igura, Takumi
    Mochizuki, Kiyoshi
    Imonaka, Kazuho
    Oshita, Mosohide
    Hagiwara, Hideki
    Mita, Eiji
    Hijiok, Taizo
    Inui, Yoshiaki
    Katayama, Kazuhiro
    Yoshihara, Horumosa
    Imai, Yosuharu
    Kato, Michio
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahoara, Akinori
    Hayashil, Norio
    HEPATOLOGY, 2008, 48 (04) : 880A - 881A
  • [37] Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B
    Duo-Duo Lv
    You-Juan Wang
    Meng-Lan Wang
    En-Qiang Chen
    Ya-Chao Tao
    Dong-Mei Zhang
    Hong Tang
    Scientific Reports, 11
  • [38] PROGRESSION TO CIRRHOSIS, HEPATOCELLULAR CARCINOMA AND LIVER RELATED MORTALITY IN ITALIAN PATIENTS WITH CHRONIC HEPATITIS B
    Ieluzzi, D.
    Covolo, L.
    Passigato, N.
    Tonon, A.
    Donato, F.
    Fattovich, G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S298 - S298
  • [39] Lifestyle risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients
    Matsuura, Tomoka
    Ohfuji, Satoko
    Enomoto, Masaru
    Tamori, Akihiro
    Kubo, Shoji
    Kioka, Kiyohide
    Fukushima, Wakaba
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50
  • [40] Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hayashi, N
    Kasahara, A
    ONCOLOGY, 2002, 62 : 87 - 93